The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
T Cell Responses Are Required for Protection from Clinical Disease and for Virus Clearance in Severe Acute Respiratory Syndrome Coronavirus-Infected Mice
Open accessAbstract
A dysregulated innate immune response and exuberant cytokine/chemokine expression are believed to be critical factors in the pathogenesis of severe acute respiratory syndrome (SARS), caused by a coronavirus (SARS-CoV). However, we recently showed that inefficient immune activation and a poor virus-specific T cell response underlie severe disease in SARS-CoV-infected mice. Here, we extend these results to show that virus-specific T cells, in the absence of activation of the innate immune response, were sufficient to significantly enhance survival and diminish clinical disease. We demonstrated that T cells are responsible for virus clearance, as intravenous adoptive transfer of SARS-CoV-immune splenocytes or in vitro -generated T cells to SCID or BALB/c mice enhanced survival and reduced virus titers in the lung. Enhancement of the number of virus-specific CD8 T cells by immunization with SARS-CoV peptide-pulsed dendritic cells also resulted in a robust T cell response, earlier virus clearance, and increased survival. These studies are the first to show that T cells play a crucial role in SARS-CoV clearance and that a suboptimal T cell response contributes to the pathological changes observed in SARS. They also provide a new approach to SARS vaccine design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“anti-S T-cell responses to the related SARS- and MERS-CoVs contribute toward viral clearance in normal as well as aged mice infected with SARS- or MERS-CoV, respectively (43–45).”
From An Alphavirus -derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates (2020) · cites this paper as [43]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873
Coronavirus as a possible cause of severe acute respiratory syndrome
Peiris, M. J. S., Lai, S., Poon, L. L. M., Guan, Y., Yam, L., Lim, W., Nicholls, J. M., Yee, W., Yan, W., Cheung, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13077-2 · Cited by 2,916
Bats Are Natural Reservoirs of SARS-Like Coronaviruses
Li, W., Shi, Z., Yu, M., Ren, W., Smith, C. S., Epstein, J. H., Wang, H., Crameri, G. S., Hú, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,571
Peiris, J., Chu, C., Cheng, V., Chan, K., Hung, I., Poon, L., Law, K., Tang, B., Hon, T., Chan, C., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13412-5 · Cited by 2,375
SYFPEITHI: database for MHC ligands and peptide motifs
Rammensee, H., Bachmann, J., Emmerich, N., Bachor, O. A., & Stevanović, S. (1999) · Immunogenetics · doi:10.1007/s002510050595 · Cited by 2,316
van Rooijen, N., & Sanders, A. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90012-4 · Cited by 1,763
MHC ligands and peptide motifs: first listing
Rammensee, H., Friede, T., & Stevanović, S. (1995) · Immunogenetics · doi:10.1007/bf00172063 · Cited by 1,638
T-cell quality in memory and protection: implications for vaccine design
Seder, R. A., Darrah, P. A., & Roederer, M. (2008) · Nature reviews. Immunology · doi:10.1038/nri2274 · Cited by 1,565
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
Yang, Z.-Y., Kong, W., Huang, Y., Roberts, A., Murphy, B., Subbarao, K., & Nabel, G. (2004) · Nature · doi:10.1038/nature02463 · Cited by 688
Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10
Sun, J., Madan, R., Karp, C. L., & Braciale, T. J. (2009) · Nature Medicine · doi:10.1038/nm.1929 · Cited by 626
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–342 of 342
T cell responses to SARS-COV-2
Khadri, L., Ziraksaz, M. H., Barekzai, A. B., & Ghauri, B. (2023) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2023.06.001 · Cited by 1
Virus Infection and Titration of SARS-CoV in Mouse Lung
Fett, C., Zhao, J., & Perlman, S. M. (2014) · BIO-PROTOCOL · doi:10.21769/bioprotoc.1084 · Cited by 1
Self-citationVitamin D Deficiency - New Insights
Fedotova, J. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100904 · Cited by 1
Ferrantelli, F., Manfredi, F., Chiozzini, C., Leone, P., Pugliese, K., Spada, M., Virgilio, A. D., Giovannelli, A., Valeri, M., Cara, A., et al. (2023) · Vaccines · doi:10.3390/vaccines11091433 · Cited by 1
Lee, P., Kim, J., Oh, H., Kim, C.-U., Jeong, A. Y., Lee, M., Jang, M. S., Hong, J. J., Park, J.-E., & Kim, D. (2024) · Antiviral Research · doi:10.1016/j.antiviral.2024.105991 · Cited by 1
A review of genetic methods and models for analysis of coronavirus-induced severe pneumonitis
McGruder, B., & Leibowitz, J. L. (2014) · Journal of General Virology · doi:10.1099/vir.0.069732-0 · Cited by 1
Interstitial lung diseases and COVID-19
Çoşkun, F., Gülhan, P. Y., Demirci, N. Y., Bozkuş, F., & Yazıcı, O. (2020) · Eurasian Journal of Pulmonology · doi:10.4103/ejop.ejop_46_20 · Cited by 1
Lethal Human Coronavirus Infections and the Role of Vaccines in Their Prevention
Baldwin, J., & Petrovsky, N. (2021) · Springer eBooks · doi:10.1007/978-3-030-71165-8_24 · Cited by 1
SARS-CoV-2 Infection and Antibody-Dependent Enhancement
Baştuğ, A., & Bodur, H. (2021) · Studies in computational intelligence · doi:10.1007/978-3-030-74761-9_5 · Cited by 1
Immunological considerations and vaccines against COVID-19
(2021) · Biomedical Letters · doi:10.47262/bl/7.1.20210501 · Cited by 1
T Cell Responses during Acute Respiratory Virus Infection
Kim, T. S., Sun, J., Legge, K. L., & Braciale, T. J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.14011-1 · Cited by 1
Sterilizing immunity against SARS-CoV-2 in hamsters conferred by a novel recombinant subunit vaccinePreprint
Wu, Y., Huang, X., Yuan, L., Wang, S., Zhang, Y., Xiong, H., Chen, R., Ma, J., Qi, R., Nie, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.18.423552 · Cited by 1
Experimental and field studies on Porcine hemagglutinating encephalomyelitis virus
Mora-Díaz, J. C. (2020) · doi:10.31274/etd-20210114-99 · Cited by 1
Pardieck, I. N., van der Gracht, E. T. I., Veerkamp, D. M. B., Behr, F. M., van Duikeren, S., Beyrend, G., Rip, J., Nadafi, R., van der Sluis, T. C., Nejad, E. B., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.15.472838 · Cited by 1
Manfredi, F., Chiozzini, C., Ferrantelli, F., Leone, P., Pugliese, K., Spada, M., Virgilio, A. D., Giovannelli, A., Valeri, M., Cara, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.19.524762 · Cited by 1
Manfredi, F., Chiozzini, C., Ferrantelli, F., Leone, P., Pugliese, K., Spada, M., Virgilio, A. D., Giovannelli, A., Valeri, M., Cara, A., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2501965/v1 · Cited by 1
InfectionsMice from Lethal Respiratory Virus Intranasal Treatment with Poly(I·C) Protects
Perlman, S. M., Fleming, E., Lane, T. E., McCray, P. B., Zhao, J., Wohlford-Lenane, C., & Zhao, J. (2012)
Self-citationRadiotherapy as a Cure for Covid-19 Pneumonia: Is this a Possibility?
Medhi, P. P., Bansal, S., Momin, F. J., & Bora, G. (2020) · Asian Pacific Journal of Cancer Care · doi:10.31557/apjcc.2020.5.s1.157-159
Daouda, T., Dumont-Lagacé, M., Feghaly, A., & Villani, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.04.429819
Cytokine Bombardment is the Major Cause for Morbidity in Sars-Cov-2 (Covid-19) Patients: A Review
Samah, S. B., Zainal, K. B., Pergasa, S., & Tiwari, K. (2021) · Annals of the Romanian Society for Cell Biology
Immunological Changes in Pregnancy and Its Relation to COVID-19 Infection
Hamza, A. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90595-4.00006-6
Rational Vaccine Design by Reverse & Structural Vaccinology and Ontology
Ong, E. (2021) · Deep Blue (University of Michigan) · doi:10.7302/1424
Clinical Manifestations of Cytokine Storm and Immune Response to COVID-19: Literature Review
Kowsarnia, S. (2021) · Open Journal of Internal Medicine · doi:10.4236/ojim.2021.113012
The characterisation of human coronavirus nl63 proteins
Gordon, B. (2021) · University of the Western Cape Electronic Theses and Dissertations Repository (University of the Western Cape)
Zhang, Q., Peng, H., Luo, Y., Ye, X., Wang, R., Shao, H., Rao, S., Zhang, Q., Luo, X., & Zhang, X. (2020) · Inflammation and Cell Signaling · doi:10.14800/ics.1150
Wu, D., Zhang, X., Ziemba, Y. C., Haghi, N., Brody, J., & Hsu, P. (2022) · Clinical Pathology · doi:10.1177/2632010x211072818
Clonal diversity determines persistence of SARS-CoV-2 epitope-specific T cell responsePreprint
Zornikova, K. V., Khmelevskaya, A. A., Sheetikov, S. A., Kiryukhin, D. O., Shcherbakova, O. V., Titov, A., Zvyagin, I. V., & Efimov, G. A. (2022) · medRxiv · doi:10.1101/2022.04.18.22273961
Immunopathogenesis and Possible Therapeutic Interventions for Covid-19: An Update
Mateen, S., Mateen, A., Khalid, A., Faizy, A. F., Shahzad, S., & Moin, S. (2021) · Research Journal of Life Sciences Bioinformatics Pharmaceutical and Chemical Sciences · doi:10.26479/2021.0701.04
РОЛЬ КЛЕТОЧНОГО ЗВЕНА ИММУНИТЕТА В ФОРМИРОВАНИИ ИММУННОГО ОТВЕТА ПРИ КОРОНАВИРУСНЫХ ИНФЕКЦИЯХPreprint
Ia, I., Omelchenko, N. D., Filippenko, A. V., Trufanova, A. A., & Носков, А. К. (2021) · doi:10.21055/preprints-3111935
Immune Response Characteristics in SARS-CoV-2 Infection
Badawi, S. (2021) · Vide Leaf, Hyderabad eBooks · doi:10.37247/imcac.1.21.15
Management of Infections in Stem Cell Transplant Recipients
Guevara, E. Y., Rahman, Z. A., Daher, M., & Mulanovich, V. E. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79833-4.00031-0
Ferrantelli, F., Manfredi, F., Chiozzini, C., Leone, P., Pugliese, K., Spada, M., Virgilio, A. D., Giovannelli, A., Valeri, M., Cara, A., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-2950996/v1
Post Covid-19 Women Complications
Patel, A. I., Yadav, A., Patel, A. B., & Vyas, A. J. (2023) · Asian Journal of Nursing Education and Research · doi:10.52711/2349-2996.2023.00017
Ali, K., Nawaz, K. H., Hassan, W. U., & Khan, R. M. W. (2023) · Pakistan Armed Forces Medical Journal · doi:10.51253/pafmj.v73i4.6705
Ex Vivo Immunization: A Strategy for Immunization Against SARS-CoV-2
Singh, H., Nuthalapati, P., Yendapalli, P., & Sahu, D. (2024) · Royal Society of Chemistry eBooks · doi:10.1039/bk9781837672813-00258
SARS-CoV-2 spike protein in infectivity
Altaie, A. M., Hamdy, R., Husseiny, M. I., & Soliman, S. S. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-19170-1.00015-2
Krickeberg, N., Rammensee, H., & Schilbach, K. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1676455
Jiang, J., Tang, R., Li, L., Kou, Z., Xing, F., Liu, X., Fu, Y., & Yi, Z. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117776
Cole, M. E., Jossi, S., Dillen, C., Fanaroff, R. E., Frieman, M. B., & Pleguezuelos, O. (2026) · Vaccines · doi:10.3390/vaccines14040288
Statistical biophysics models of immune repertoire dynamics
Koraichi, M. B. (2022) · theses.fr (ABES) · doi:10.70675/625cdda6zca1dz443dzb6f4z3637549945b7
Host Factor Experiment (DiegoM_AUM_01_Mouse_SARS_Expression)
J. Craig Venter Institute, & University of Chicago (2015) · Virus Pathogen Resource · doi:10.35083/36nd-sx41
T and B cell responses to SARS-CoV-2 coronavirus
Sette, A. (2020) · ImmPort · doi:10.21430/m3czdhcxkv
Metadata
- Authors
- Zhao, J., Zhao, J., & Perlman, S.
- Affiliations
- University of Iowa (US)
- Corresponding author
- Perlman, Stanley
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2010-09-15
- Volume
- 84
- Issue
- 18
- Pages
- 9318-9325
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- PMC
- PMC2937604
- OpenAlex
- W1999546368
- Cited by
- 340
- References
- 36
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 10 · 2023: 28 · 2022: 52 · 2021: 76 · 2020: 122 · 2019: 4 · 2018: 3 · 2017: 3 · 2016: 11 · 2015: 4 · 2014: 9 · 2013: 2 · 2012: 4
- FWCI
- 1.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Virology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (PO1AI060699, AI060699)
- National Institute of Allergy and Infectious Diseases (R21AI079429, R56AI079429, P01AI060699)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Health Sciences › Medicine › Infectious Diseases › Viral Infections and Outbreaks Research
- Keywords
- SARS, SARS-CoV, T cell response, CD8+ T cells, viral clearance, adoptive T cell therapy, dendritic cell immunization, innate immune response, lung viral titers, SARS pathogenesis
- MeSH terms
- Animals, Lung, Mice, Inbred BALB C, Spleen, T-Lymphocytes, Viral Vaccines, Survival Analysis, Mice, SCID, Adoptive Transfer, Severe Acute Respiratory Syndrome, Severe acute respiratory syndrome-related coronavirus, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review